NEOGENOMICS LABORATORIES INC has a total of 19 patent applications. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets biotechnology, computer technology and measurement are GUANGZHOU KANGXINRUI GENE HEALTH TECH CO LTD, SHANGHAI CHROMYSKY MEDICAL RES CO LTD and BIOCHAIN BEIJING SCIENCE & TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 5 | |
#3 | Australia | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Computer technology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Data recognition and presentation | |
#3 | Analysing materials | |
#4 | Computational chemistry | |
#5 | Electrotherapy | |
#6 | Bioinformatics | |
#7 | Combinatorial chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Albitar Maher | 17 |
#2 | Zhang Hong | 3 |
#3 | Maher Albitar | 1 |
#4 | Albitar Maher M | 1 |
Publication | Filing date | Title |
---|---|---|
US2017051357A1 | High-sensitivity sequencing to detect BTK inhibitor resistance | |
US2017002427A1 | Method for high sensitivity detection of MYD88 mutations | |
US2016340725A1 | Method to increase sensitivity of detection of low-occurrence mutations | |
EP3230887A1 | Automated flow cytometry analysis method and system | |
CA2969912A1 | Automated flow cytometry analysis method and system | |
US2016130664A1 | Determining tumor load and biallelic mutation in patients with CALR mutation using peripheral blood plasma | |
EP3218520A1 | Deep sequencing of peripheral blood plasma dna is reliable for confirming the diagnosis of myelodysplastic syndrome | |
EP2971177A1 | Compositions and methods for detecting and determining a prognosis for prostate cancer |